Publicaciones en colaboración con investigadores/as de Clínica Universitaria de Navarra (15)

2024

  1. Neoadjuvant therapy versus upfront surgery in resectable pancreatic cancer: reconstructed patient-level meta-analysis of randomized clinical trials

    BJS open, Vol. 8, Núm. 5

2021

  1. Feasibility and patency of echoendoscopic anastomoses with lumen apposing metal stents depending on the gastrointestinal segment involved

    Scientific Reports, Vol. 11, Núm. 1

2019

  1. Use of machine-learning algorithms in intensified preoperative therapy of pancreatic cancer to predict individual risk of relapse

    Cancers, Vol. 11, Núm. 5

2015

  1. Long-term oncologic results in cancer of the rectum treated by preoperative chemoradiotherapy and surgery: An analysis of 500 cases

    Revista Espanola de Enfermedades Digestivas, Vol. 107, Núm. 6, pp. 340-346

2014

  1. Analysis of surgical complications of primary tumor resection after neoadjuvant treatment in stage IV colon cancer

    Journal of Gastrointestinal Oncology, Vol. 5, Núm. 2, pp. 148-153

2013

  1. Prognosis factors for recurrence in patients with locally advanced rectal cancer preoperatively treated with chemoradiotherapy and adjuvant chemotherapy

    Diseases of the Colon and Rectum, Vol. 56, Núm. 4, pp. 416-421

2012

  1. Four-week neoadjuvant intensity-modulated radiation therapy with concurrent capecitabine and oxaliplatin in locally advanced rectal cancer patients: A validation phase II trial

    International Journal of Radiation Oncology Biology Physics, Vol. 83, Núm. 2, pp. 587-593

2011

  1. Association of RRM1 -37A>C polymorphism with clinical outcome in colorectal cancer patients treated with gemcitabine-based chemotherapy

    European Journal of Cancer, Vol. 47, Núm. 6, pp. 839-847

2010

  1. Dose-finding study and pharmacogenomic analysis of fixed-rate infusion of gemcitabine, irinotecan and bevacizumab in pretreated metastatic colorectal cancer patients

    British Journal of Cancer, Vol. 103, Núm. 10, pp. 1529-1535

  2. Oxaliplatin, irinotecan and capecitabine as first-line therapy in metastatic colorectal cancer (mCRC): A dose-finding study and pharmacogenomic analysis

    British Journal of Cancer, Vol. 102, Núm. 6, pp. 987-994

2008

  1. Liver disease induced by radioembolization of liver tumors: Description and possible risk factors

    Cancer, Vol. 112, Núm. 7, pp. 1538-1546

  2. Preliminary results of the combination of bevacizumab and weekly paclitaxel in advanced melanoma

    Oncology, Vol. 74, Núm. 1-2, pp. 12-16

2006

  1. Ileal carcinoid tumor with liver metastases and cardiac involvement treated with intraarterial liposomal doxorubicin and valve replacement

    Clinical and Translational Oncology, Vol. 8, Núm. 5, pp. 369-371

  2. Some evaluation tools used in Palliative Care (II): The Brief Pain Inventory (BPI)

    Medicina Paliativa, Vol. 13, Núm. 1, pp. 37-42

2005

  1. Assessment of the value of confirming responses in clinical trials in oncology

    European Journal of Cancer, Vol. 41, Núm. 11, pp. 1528-1532